Not finding it? Sign in to also search OpenAlex live.
-
Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Matthias R. Zaiss, Kathrin Engelken, +11 more
7citations
6 results